Monitoring Patients with Metastatic Hormone-Sensitive and Metastatic Castration-Resistant Prostate Cancer: A Multidisciplinary Consensus Document

Background: The availability of a number of agents that are efficacious in patients with metastatic prostate cancer (mPC) has led to them being used sequentially, and this has prolonged patient survival. However, in order to maximize their efficacy, clinicians need to be able to obtain a reliable pi...

Descripción completa

Detalles Bibliográficos
Autores principales: Lapini, Alberto, Caffo, Orazio, Pappagallo, Giovanni, Iacovelli, Roberto, D’Angelillo, Rolando Maria, Vavassori, Vittorio, Ceccarelli, Roberta, Bracarda, Sergio, Jereczek-Fossa, Barbara Alicja, Da Pozzo, Luigi, Conti, Giario Natale
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966424/
https://www.ncbi.nlm.nih.gov/pubmed/31805687
http://dx.doi.org/10.3390/cancers11121908

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966424/
https://www.ncbi.nlm.nih.gov/pubmed/31805687
http://dx.doi.org/10.3390/cancers11121908

Ejemplares similares